chr8-37750426-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 3P and 2B. PM2PP2BP4BP6
The NM_007175.8(ERLIN2):c.589G>A(p.Ala197Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,558 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_007175.8 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 18Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
- juvenile primary lateral sclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- recessive intellectual disability-motor dysfunction-multiple joint contractures syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ERLIN2 | NM_007175.8 | c.589G>A | p.Ala197Thr | missense_variant | Exon 9 of 12 | ENST00000519638.3 | NP_009106.1 | |
| ERLIN2 | NM_001362878.2 | c.589G>A | p.Ala197Thr | missense_variant | Exon 9 of 12 | NP_001349807.1 | ||
| ERLIN2 | XM_047421307.1 | c.589G>A | p.Ala197Thr | missense_variant | Exon 10 of 13 | XP_047277263.1 | ||
| ERLIN2 | XM_047421308.1 | c.343G>A | p.Ala115Thr | missense_variant | Exon 6 of 9 | XP_047277264.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ERLIN2 | ENST00000519638.3 | c.589G>A | p.Ala197Thr | missense_variant | Exon 9 of 12 | 2 | NM_007175.8 | ENSP00000428112.1 | ||
| ERLIN2 | ENST00000521644.5 | c.589G>A | p.Ala197Thr | missense_variant | Exon 9 of 12 | 5 | ENSP00000429621.1 | |||
| ERLIN2 | ENST00000518526.5 | c.460G>A | p.Ala154Thr | missense_variant | Exon 7 of 8 | 3 | ENSP00000429229.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152110Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 250998 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461448Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727008 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152110Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74314 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.589G>A (p.A197T) alteration is located in exon 9 (coding exon 8) of the ERLIN2 gene. This alteration results from a G to A substitution at nucleotide position 589, causing the alanine (A) at amino acid position 197 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Spastic paraplegia Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at